- Home
- RZLT vs ORIC Comparison
RZLT vs ORIC Comparison
Compare RZLT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- ORIC
- Stock Information
- Founded
- RZLT 2010
- ORIC 2014
- Country
- RZLT United States
- ORIC United States
- Employees
- RZLT N/A
- ORIC N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- RZLT Health Care
- ORIC Health Care
- Exchange
- RZLT Nasdaq
- ORIC Nasdaq
- Market Cap
- RZLT 361.3M
- ORIC 362.9M
- IPO Year
- RZLT N/A
- ORIC 2020
- Fundamental
- Price
- RZLT $5.26
- ORIC $11.10
- Analyst Decision
- RZLT Strong Buy
- ORIC Strong Buy
- Analyst Count
- RZLT 6
- ORIC 9
- Target Price
- RZLT $12.00
- ORIC $18.29
- AVG Volume (30 Days)
- RZLT 1.4M
- ORIC 964.9K
- Earning Date
- RZLT 05-13-2025
- ORIC 08-11-2025
- Dividend Yield
- RZLT N/A
- ORIC N/A
- EPS Growth
- RZLT N/A
- ORIC N/A
- EPS
- RZLT N/A
- ORIC N/A
- Revenue
- RZLT N/A
- ORIC N/A
- Revenue This Year
- RZLT $35.39
- ORIC N/A
- Revenue Next Year
- RZLT N/A
- ORIC N/A
- P/E Ratio
- RZLT N/A
- ORIC N/A
- Revenue Growth
- RZLT N/A
- ORIC N/A
- 52 Week Low
- RZLT $2.22
- ORIC $3.90
- 52 Week High
- RZLT $6.19
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- RZLT 74.51
- ORIC 66.82
- Support Level
- RZLT $4.15
- ORIC $10.42
- Resistance Level
- RZLT $5.39
- ORIC $11.50
- Average True Range (ATR)
- RZLT 0.30
- ORIC 0.62
- MACD
- RZLT 0.08
- ORIC -0.03
- Stochastic Oscillator
- RZLT 90.85
- ORIC 83.30
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.